ReviewJournal for immunotherapy of cancer2022

Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects.

Solange Peters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.